Impact of the loss of Laboratory Developed Mass Spectrometry testing at a major academic medical center
Description
CONCLUSIONS: Barriers that discourage laboratories from developing in-house testing, particularly in the absence of FDA-cleared alternatives, can be expected to have a detrimental effect on patient care and hospital finances.
